April 10, 2024

The ChemQuest Group has welcomed two new global leaders to its team. Sharon Feng, Ph.D., has been named a vice-president, while Prem Patel has joined the firm as a director.

Sharon Feng began her career with Bayer Corp., rising through the ranks and developing expertise in organic pigments, polymer resins, and emerging coating technologies such as waterborne, high-solids, powder, and UV coatings before being named vice-president of business development for the coatings, adhesives, and specialties segment of Bayer MaterialScience for the Asia-Pacific region. Subsequently, she served in three vice-president roles, leading EHS, supply chain, and innovation functions with both Lanxess Corp. and Bayer MaterialScience North America.

Feng later transitioned to research and development (R&D) leadership positions with PPG Industries, most recently serving as global technical director for Corporate R&D. In addition, Feng has been an independent director on the board of Koppers Inc. since 2009. She earned a doctorate in chemistry from the Massachusetts Institute of Technology, an MS in chemistry from the University of California at Davis, and a combined BS/MS in chemistry from Nanjing University.

Over his career, Prem Patel has developed extensive strategy, marketing, sales, operations, and product development experience in B2B value chains. In roles for companies such as Rogers Corp., Lear Corp., and Milliken & Co., he has been successful in growing P&Ls by leading and scaling strategy, M&A, product management, innovation, and operations initiatives across global value chains.

Patel most recently served as director of Corporate Strategy and Growth Options for Ingevity Corp. He holds an MBA from Duke University and a BS in chemical engineering from Case Western Reserve University.

Feng and Patel will draw on their considerable expertise to support ChemQuest’s Business Strategy & Transformation and M&A Advisory Services pillars. In addition, Feng will assist Technology Development clients in pursuing their R&D goals.